JK07 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-31 in 3mo
ESTIMATED |
READOUT
Study of JK07 in Patients With Chronic Heart Failure
Phase 2 · Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction |
Salubris Biotherapeutics Inc | JK07 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|